Company Bioventus Inc.

Equities

BVS

US09075A1088

Medical Equipment, Supplies & Distribution

Market Closed - Nasdaq 04:00:00 2024-04-25 pm EDT 5-day change 1st Jan Change
4.07 USD -1.93% Intraday chart for Bioventus Inc. -10.55% -22.77%

Business Summary

Bioventus Inc. is a medical device company. The Company is focused on developing and commercializing clinically differentiated and minimally invasive treatments that engage and enhance the body’s natural healing process. Its portfolio of products is grouped into three areas. Its Pain Treatments include non-surgical pain injection therapies as well as peripheral nerve stimulation (PNS) products to help the patient get back to their normal activities. Its Surgical Solutions include bone graft substitutes (BGS) that increase bone formation to stimulate bone healing in spinal fusions and other orthopedic surgeries, as well as a portfolio of ultrasonic products used for precise bone cutting and sculpting, soft tissue management and tissue debridement in various surgeries. Its Restorative Therapies comprise a bone stimulation system, as well as devices designed to help patients regain leg or hand function due to stroke, multiple sclerosis or other central nervous system disorders.

Number of employees: 970

Sales per Business

USD in Million2022Weight2023Weight Delta
Pain Treatments
43.1 %
216 42.2 % 221 43.1 % +2.07%
Surgical Solutions
30.1 %
141 27.6 % 154 30.1 % +9.43%
Restorative Therapies
26.8 %
155 30.2 % 137 26.8 % -11.36%

Sales per region

USD in Million2022Weight2023Weight Delta
United States
87.8 %
455 88.9 % 450 87.8 % -1.18%
International
12.2 %
57 11.1 % 62 12.2 % +9.88%

Managers

Managers TitleAgeSince
Chief Executive Officer - Jan. 09
Director of Finance/CFO 55 22-03-20
Compliance Officer 62 -
Investor Relations Contact - 21-08-22
Human Resources Officer - 22-05-31
Corporate Officer/Principal - 17-03-31
Corporate Officer/Principal - 12-04-30
General Counsel 63 17-07-31

Members of the board

Members of the board TitleAgeSince
Chairman 70 16-06-29
Director/Board Member 63 19-12-31
Director/Board Member 68 16-06-29
Director/Board Member 71 20-08-31
Director/Board Member 75 19-12-31
Director/Board Member 53 23-01-07
Director/Board Member 57 21-07-14
Director/Board Member 56 16-06-29
Director/Board Member 58 21-10-28
Director/Board Member 54 21-12-31

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 15,786,737 0 0 67.01 %
Stock B 1 63,378,803 53,051,569 ( 83.71 %) 0

Shareholders

NameEquities%Valuation
Essex Woodlands Management, Inc.
20.55 %
13,021,324 20.55 % 68 M $
Juniper Investment Co. LLC
10.78 %
6,833,857 10.78 % 36 M $
6,229,991 9.830 % 32 M $
Nantahala Capital Management LLC
9.431 %
5,977,471 9.431 % 31 M $
Spindletop Healthcare Capital LP
6.164 %
3,906,395 6.164 % 20 M $
Ampersand Management LLC
5.136 %
3,255,332 5.136 % 17 M $
Vanguard Global Advisers LLC
1.923 %
1,218,500 1.923 % 6 M $
Kent Lake Capital LLC
0.8408 %
532,880 0.8408 % 3 M $
BlackRock Institutional Trust Co. NA
0.7894 %
500,285 0.7894 % 3 M $
Geode Capital Management LLC
0.6429 %
407,444 0.6429 % 2 M $
NameEquities%Valuation
15,786,737 100.00 % 82 M $
NameEquities%Valuation
15,786,737 - 82 M $

Company contact information

Bioventus, Inc.

4721 Emperor Boulevard Suite 100

27703, Durham

+

http://www.bioventus.com
address Bioventus Inc.(BVS)

Sales per Business

Sales per region

Trading Rating
Investor Rating
ESG Refinitiv
C
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
3
Last Close Price
4.15 USD
Average target price
8 USD
Spread / Average Target
+92.77%
Consensus
  1. Stock Market
  2. Equities
  3. BVS Stock
  4. Company Bioventus Inc.